missing translation for 'onlineSavingsMsg'
Learn More

LanthaScreen™ LanthaScreen™ TR-FRET Glucocorticoid Receptor Coactivator Assay Kit

Product Code. 15637858
Change view
Click to view available options
Quantity:
800 x 20 μL assays
Unit Size:
Pack of 800
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
15637858 800 x 20 μL assays Pack of 800
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Product Code. 15637858 Supplier LanthaScreen™ Supplier No. A15899
 Restricted Item
Estimated Shipment: 21-08-2026
Add to basket
Add to basket
This item is not returnable. View return policy

LanthaScreen™ TR-FRET Glucocorticoid Receptor Coactivator Assay Kit provides a sensitive and robust method for high-throughput screening of potential glucocorticoid receptor (GR) ligands as agonists or antagonists of ligand-dependent coactivator recruitment.

  • The LanthaScreen™ TR-FRET Glucocorticoid Receptor Coactivator Assay Kit provides a sensitive and robust method for high-throughput screening of potential glucocorticoid receptor (GR) ligands as agonists or antagonists of ligand-dependent coactivator recruitment. The kit uses a human recombinant GR ligand-binding domain (GR-LBD) tagged with glutathione-S-transferase (GST) (also available separately), a terbium (Tb)-labeled anti-GST antibody, and a fluorescein-labeled coactivator peptide in a homogeneous mix-and-read assay format.
  • Agonist Mode - When running the LanthaScreen TR-FRET Glucocorticoid Receptor Coactivator Assay in agonist mode (to identify agonist compounds), GR-LBD is added to ligand test compounds, followed by the addition of a mixture of fluorescein-coactivator peptide and Tb-labeled anti-GST antibody. After incubation at room temperature, the 520/495 nm TR-FRET ratio is calculated and can be used to determine the EC50 from a dose response curve of the compound. Based on the biology of the GR-coactivator peptide interaction, this ligand EC50 is a composite value representing the amount of ligand required to bind to receptor, effect a conformational change, and recruit coactivator peptide.
  • Antagonist Mode - When the LanthaScreen TR-FRET Glucocorticoid Receptor Coactivator Assay is run in antagonist mode (to identify antagonist compounds), GR-LBD is added to ligand test compounds followed by the addition of a mixture of agonist, fluorescein-coactivator peptide, and Tb-labeled anti-GST antibody. The concentration of agonist used in this mode is the EC80 concentration as determined by first running the assay in agonist mode.
  • Includes:
    • 1 tube GR Ligand Binding Domain Recombinant Protein (store at -68 to -85°C)
    • 1 tube of Peptide (store at -5 to -30°C)
    • 2 bottles TR-FRET Buffer (store at -5 to -30°C)
    • 1 vial Tb-Anti-GST Ab (store at -5 to -30°C)
    • 1 tube of DTT (store at -5 to -30°C)
TRUSTED_SUSTAINABILITY

Specifications

Content And Storage 1 tube GR Ligand Binding Domain Recombinant Protein (store at -68 to -85°C)
1 tube of Peptide (store at -5 to -30°C)
2 bottles TR-FRET Buffer (store at -5 to -30°C)
1 vial Tb-Anti-GST Ab (store at -5 to -30°C)
1 tube of DTT (store at -5 to -30°C)
For Use With (Application) Co-Factor Interaction Assay, Nuclear Receptor Assay
Product Line LanthaScreen
Quantity 800 x 20 μL assays
Type Coactivator Assay Kit

For Research Use Only. Not for use in diagnostic procedures.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.